The Poirazi lab is the recipient of and will coordinate a new FET-OPEN grant entitled “A smart, hybrid neural-silico-computo device for drug discovery (Acronym: NEUREKA). The program involves the development of a novel hybrid technology, whereby nanoelectrodes and sophisticated computational models of neuronal circuits are combined to readout and manipulate activity/connectivity in cultured neuronal networks of Alzheimer’s disease, with subcellular accuracy. The consortium includes, in addition to FORTH, the University of Padova (Italy), the University of Milan Bicocca (Italy), the Centre National de la Recherche Scientifique (CNRS in France) and the Maxwell Biosystems AG (Switzerland) as partners.
